Company · CIK 1781174

# Acrivon Therapeutics, Inc.

| CIK | [1781174](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001781174) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | MA |
| Listed | ACRV (Nasdaq) |
| First annual or quarterly report | 2022-12-15 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-278761 | Shelf Effective | 2024-04-17 | 2024-04-29 | 2 |
| 333-275854 | Shelf Effective | 2023-12-01 | 2023-12-15 | 2 |
| 333-267911 | IPO Final prospectus | 2022-10-17 | 2022-11-16 | 5 |

## Filings

 10

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-04-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1781174/999999999524001188/9999999995-24-001188-index.htm) Declared effective | 333-278761 | 9999999995-24-001188 |
| 2024-04-17 | [S-3](https://www.sec.gov/Archives/edgar/data/1781174/000119312524099152/0001193125-24-099152-index.htm) Shelf registered | 333-278761 | 0001193125-24-099152 |
| 2023-12-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1781174/999999999523003657/9999999995-23-003657-index.htm) Declared effective | 333-275854 | 9999999995-23-003657 |
| 2023-12-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1781174/000119312523287501/0001193125-23-287501-index.htm) Shelf registered | 333-275854 | 0001193125-23-287501 |
| 2022-11-16 | [424B4](https://www.sec.gov/Archives/edgar/data/1781174/000119312522286805/0001193125-22-286805-index.htm) Final prospectus | 333-267911 | 0001193125-22-286805 |
| 2022-11-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1781174/999999999522003246/9999999995-22-003246-index.htm) Declared effective | 333-267911 | 9999999995-22-003246 |
| 2022-11-08 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1781174/000119312522279682/0001193125-22-279682-index.htm) Amendment | 333-267911 | 0001193125-22-279682 |
| 2022-11-03 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1781174/000119312522276311/0001193125-22-276311-index.htm) Amendment | 333-267911 | 0001193125-22-276311 |
| 2022-10-17 | [S-1](https://www.sec.gov/Archives/edgar/data/1781174/000095012322010286/0000950123-22-010286-index.htm) Registration filed | 333-267911 | 0000950123-22-010286 |
| 2022-08-12 | [DRS](https://www.sec.gov/Archives/edgar/data/1781174/000095012322008876/0000950123-22-008876-index.htm) Draft made public | 377-06317 | 0000950123-22-008876 |

[All filings of this company](https://equitycapital.markets/filings?cik=1781174) · [CSV](https://equitycapital.markets/filings.csv?cik=1781174)

---
Source page: https://equitycapital.markets/company/1781174 · Data: U.S. SEC EDGAR · CC BY 4.0